2015年藥學大會暨第十五屆藥師a7男醫(yī)院

馬勝男*（市第四藥劑科，市2014871結果：87177.61%61.56%，占3位的是氫氯吡格雷片、舒血寧注射液、長春了解神經內科住院患者用藥特點具有積極的臨床意義，故對我院神經內科2014871通過醫(yī)院信息管理系統(tǒng)(HIS)2014871Excel=用藥總量/DDDDDDs[作者簡介]馬勝男,藥師,研究方向：醫(yī)院藥學，: ,E-mail:1。203204DDDs20DDDs205 Resultofdiseases比例腦55CVD419 Classificationofdrugutilizationofinpatientsinneurology金額(元構成比123抗藥456789抗藥320 Top20drugsinthetermsofconsumption125mg/25ml/310mg/420mg/50.125g/66mg/740mg/890.2g/注射用哌拉西林/1.125g/0.1g/2ml/5ml/10mg/46.5mg/2ml/10ml/500ug/B170mg/ Top20drugsinthetermsofconsumption140mg/210mg/32ml/45ml/5200mg/60.2g/75ml/810ml/910ml/2ml/注射用哌拉西林/1.125g/1g/25mg/注射用頭孢哌酮鈉/1.5g/40mg/0.1g/0.4mg/5mg/250ml/ DDDs排序列前20位的藥品統(tǒng)110mg/225mg/110mg/225mg/340mg/4510mg/6100mg/720mg/85ml/920mg/5ml/200mg/6mg/250ml/醒腦靜注射 ml/ 2ml/500ug/0.2g/厄貝沙坦氫30mg/10ml/1中神經內科住院患者病種中可以發(fā)現(xiàn)，居神經內科住院患者數前3位的分別為：短暫性腦缺血發(fā)作、腦梗死和CVD后遺癥?；紨底疃嗟那?種疾病中，4/5為腦血管病，其中腦血管病(TIA+腦梗死+腦+CVD后遺癥)占住院患者人數的81.17%，缺血性腦血管病(TIA+腦梗死)占住院患者人數的320司匹林聯(lián)用于心血管疾病高風險患者卒中的預防，但的研究[3]期（<1個月）的聯(lián)合應用能有效且安全地預防卒中風險，而長期（>3個月）的一般使用質子泵抑制劑（PPI）來預防，但聯(lián)用PPI會增加此類患者的血栓7位。420位的藥品，注射劑占絕大部節(jié)苷脂鈉的DDDs均列第3位，其應用數量列11位。NHISS（神經功能缺損）評分，提高ADL（生活活動能力）評分，臨床療效顯CRP陳,解勤之,李清.急性冠脈綜合征患者氯吡抵抗與近期療效的臨床觀察[J].中國臨床藥理學與治療學,2009,14(3):328-332.NyiroG,Inczedy-FarkasG,RemenyiV,etal.TheeffectoftheCYP2C19*2polymorphismonstrokecare[J].ActaPhysiolHung,2012,99(1):33-39.ShuyingChen,QingyuShen,YameiTang,etal.Efficacyandsafetyofclopidogreltoaspirinonstrokepreventionamonghighvascularriskpatients:ameta-ysisofrandomizedcontrolledtrials[J].PlosOne,2014,9(8):1-10.AngiolilloDJ,GibsonCM,ChengS,etal.Differentialeffectsofomeprazoleandpantoprazoleonthepharmacodynamicsandpharmacokineticsofclopidogrelinhealthysubjects:randomized,cebo-controlled,crossovercomparisonstudies[J].ClinPharmacolTher,2011,89:65-74. 抗血小板藥物消化道損傷的預防和治療中國專家共識組.抗血小板藥物消化道損傷的預防和治療中國專家共識.中華內科，2013,52:264-270.,.單唾液酸四己糖神經節(jié)苷脂治療老年人急性心肌梗死療效觀察[J].中西醫(yī)結合心腦血管病,2014,12(2):199-200.,男,,等.瑞舒伐他汀鈣片治療老年急性腦梗死的臨床療效觀察[J].臨床醫(yī)學,2015,(4):34-35.,藍崧,.阿托伐他汀鈣對急性腦梗死患者C-反應蛋白水平和腦梗死復發(fā)的影響[J].中國實用神經疾病,2010,13(4):7-9. KarS,ChockalingamA.Statin-associatedrhabdomyolysiswithacuterenalfailurecomplicatedbyintradialyticNSTE-MI:areviewoflipidmanagementconsiderations[J].AmJTherap,2013,20(1):57-60.ysisofDrugsUtilizationofInpatientsinNeurologyDepartmentofOurHospitalSheng-NanMa(DepartmentofPharmacy,Tianjin4thCenterHospital,Tianjin)OBJECTIVE:Toevaluatedrugutilizationofinpatientsinneurologydepartmentofourhospital.METHODS:Categoryofdrugs,consumptionamount,consumptionsum,DDDsof871casesinneurologydepartmentofourhospitalin2014wereyzedretrospectively.RESULTS:Oftotal871inpatients,patientswithstrokeaccountedfor77.61%.Nervoussystemagentswasusedwiththelargestamountinthepatients,andtheratioreachedto61.56%.Thefirst3drugsinthelistofconsumptionamountwereClopidogrelbisulfatetablets,Shuxueninginjection,Vinpocetineinjection.Thefirstfirst3drugsinthelistofconsumptionsumMonosialogangliosideinjection,Vinpocetineinjection,alprostadilinjection.RosuvastatinCalciumTablets,ClopidogrelbisulfatetabletsandMonosialogangliosideinjectiontookupthefirst3cesinthelistofDDDs.CONCLUSION:InpatientsinneurologydepartmentmainlysufferfromcerebrovasculardiseaseandaretreatedwithTCMforactivatingbloodandeliminatingstasisandnervoussystemagent